Mode
Text Size
Log in / Sign up

Colonic stents versus diverting stoma for malignant left-sided colorectal obstruction show similar long-term oncologic results.

Colonic stents versus diverting stoma for malignant left-sided colorectal obstruction show similar l…
Photo by Navy Medicine / Unsplash
Key Takeaway
Consider colonic stents as a bridge to surgery for malignant left-sided obstruction, noting similar 5-year survival to diverting stoma in this small cohort.

This single-center retrospective cohort study evaluated long-term oncologic outcomes in patients treated for malignant left-sided colorectal obstruction. The study population included 24 patients treated with colonic stents and 32 patients who underwent a diverting stoma. The primary outcome was cumulative 5-year overall survival, while secondary outcomes included 30-day complications, stent-related perforation, local recurrence, and median time from acute treatment to resection surgery. Follow-up duration was 5 years.

Regarding the primary outcome, cumulative 5-year overall survival was 63% in the stent group compared to 77% in the stoma group. The difference was not statistically significant (p = 0.319). For the secondary outcome of median time from acute treatment of obstruction to resection surgery, the duration was 30 days in the stent group and 55 days in the stoma group. There were no differences between the two groups regarding 30-day complications.

Safety analysis revealed a stent-related perforation rate of 1/24 (4.2%) in the stent group. Local recurrence occurred in two cases in the stent group and two cases in the stoma group (p = 1.0). The study authors noted that the lack of significant difference in survival may be due to a type II error, as larger studies are needed to confirm these results.

Study Details

Study typeCohort
EvidenceLevel 3
PublishedApr 2026
View Original Abstract ↓
PurposeTo evaluate the long-term oncologic results in patients treated for malignant left-sided colorectal obstruction with colonic stent or a deviating stoma as bridge to surgery.MethodsThis was a single-center, retrospective cohort study comparing survival between 24 patients treated with stents for acute left-sided malignant obstruction and 32 patients who underwent a diverting stoma from 2003 to 2014. All patients subsequently underwent resection surgery with curative intent.ResultsThere were no significant differences between the two groups regarding age, sex, ASA classification, adjuvant chemotherapy, or tumor stage. Median time from acute treatment of obstruction to resection surgery was 30 days in the stent group and 55 days in the stoma group. There were no differences in 30-day complications between the two groups, neither for complications related to the stent or stoma intervention nor for overall complications. Stent-related perforation rate was 1/24 (4.2%). The cumulative 5-year overall survival was 63% in patients treated with a stent and 77% in patients treated with a stoma (p = 0.319). There were two cases of local recurrence in each group (p = 1.0).ConclusionsWe found no differences in short-term complications or long-term oncologic outcomes between the two treatment groups. However, this may be due to a type II error, and larger studies are needed to confirm these results.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.